Clinical Trials List
Protocol Number98-2160A
Not yet recruiting
2009-09-01 - 2012-12-31
Phase II
Terminated1
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Yi-Hsin Weng Division of Neurology
- 林衛邑 Division of Neurology
- Tzu-Chen Yen Division of Nuclear Medicine
- Kun-Ju Lin Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
0 participants
